Detailed price information for Biolife Solutions (BLFS-Q) from The Globe and Mail including charting and trades.
The CFO sold 30,000 shares for $771,600. This transaction represented 16.4% of Wichterman's direct holdings, reducing his direct stake to 152,769 shares. Transaction value based on SEC Form 4 weighted ...
BioLife Solutions also reported earnings per share of $0.01, exceeding the anticipated loss of $0.01. This represents a significant 200% surprise in earnings performance. Additionally, H.C. Wainwright ...
New conference and laboratory facility to showcase the company's product portfolio and serve as a research and training hub to advance biopreservation and cell processing innovation BOTHELL, Wash., ...
BioLife Solutions, Inc. (BLFS) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to a loss of $0.02 per share a year ...
BioLife Solutions reported its Q3 2025 earnings, demonstrating a stronger-than-expected performance with a revenue of $28.1 million, surpassing the forecast of $25.69 million. The company also ...
BOTHELL, Wash., Oct. 23, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") ...
BioLife Solutions, Inc. (BLFS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
BioLife Solutions, an established biotech firm, is poised to benefit from the booming cell and gene therapy sector, projected to grow significantly by 2030. Despite recent negative EPS, BioLife has ...
BOTHELL, Wash., March 18, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction tools and services for the cell ...
TD Cowen analyst Brendan Smith maintained a Buy rating on BioLife Solutions (BLFS – Research Report) today. The company’s shares closed today at $27.26. Discover the latest stocks recommended by top ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results